Local production of medicines in Mozambique: at crossroads of pharmaceutical knowledge circulation by Brossard Antonielli, Alila
 




Local production of medicines in Mozambique: at








Espaces et SOciétés (UMR 6590)
 
Electronic reference
Alila Brossard Antonielli, “Local production of medicines in Mozambique: at crossroads of
pharmaceutical knowledge circulation”, Revue francophone sur la santé et les territoires [Online], Healthy
circulation: products, knowledge, people on the move, Online since 16 December 2019, connection on
06 April 2021. URL: http://journals.openedition.org/rfst/784 ; DOI: https://doi.org/10.4000/rfst.784 
This text was automatically generated on 6 April 2021.
La Revue francophone sur la santé et les territoires est mise à disposition selon les termes de la Licence
Creative Commons Attribution - Pas d’Utilisation Commerciale - Partage dans les Mêmes Conditions
4.0 International.
Local production of medicines in




1 In  the  first  years  after  its  independence  in  1975,  Mozambique  had  a  voluntarist
pharmaceutical policy that prioritised essential generic medicines, in accordance with
the World Health Organization’s policies at the time of ‘Health for All’ and the Alma-Ata
Conference. Several initiatives to install local production of medicines in Mozambique
were started in the late 1970s–1980s with International support from United Nations
Agencies, bilateral cooperation from European and Socialist countries and a Swedish
multinational pharmaceutical company. UNIDO experts from Hungary and Bangladesh
did install an Oral Rehydration Salts production unit in Beira City, funded by PNUD.
The  EMOFAR  plant  (Mozambique  Pharmaceutical  Enterprise,  in  its  Portuguese
acronym) did not manage to produce at full capacity in a context of economic crisis,
structural adjustment, civil war and lack of professionals with the requirements to be
trained for its management and production process and closed around 1989.
2 In 2008, the Mozambican government acquired a bankrupted private pharmaceutical
serum  plant  in  order  to  receive  a  transfer  of  technology  and  skills  training  from
Brazilian  Ministry  of  Health  State  owned  laboratory  Farmanguinhos.  The  new
Mozambican factory, named Mozambican Society of Medicines (SMM in its Portuguese
acronym), was first conceived to produce antiretrovirals for HIV/AIDS treatment, but
Mozambican health authorities negotiated with their Brazilian counterparts to include
other  essential  medicines  in  its  portfolio.  By  including  common  antidiabetic,
hypertension and analgesic drugs, Mozambican health officials linked this South-South
Cooperation project with their 1970s pharmaceutical policies centred on the Essential
Medicines List. The Brazilian government funded the equipment, the training and the
raw materials.  The training of Mozambican technicians and managers by a team of
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Brazilian  pharmacists,  chemists  and  engineers  with  extensive  work  experience  in
private-owned pharmaceutical plants in Brazil, took place in Mozambique and in Brazil.
The transfer of knowledge and skills and building capabilities is ongoing since 2008,
with phases of theoretical and practical (on-the-job) training. The participants stressed
that the technological learning process also encompassed the acquisition of managerial
skills and of international certification norms such as Good Manufacturing Practices.
This  process  revealed  the  challenges  of  transferring  knowledge  between  two
asymmetrical  personnel,  in  terms  of  initial  training  and  work  experience.  The
retention  of  trained  Mozambican  professionals  in  a  context  with  limited  qualified
professionals is also problematic.
3 Moreover, some Mozambican authorities and their Brazilian partners still debate the
aims of this enterprise: to produce generic drugs exclusively for the Ministry of Health
supply or to export production to generate revenue for the Mozambican State.  The
economic resiliency of SMM in put under strain by the competition of medicine imports
from international donors, such as PEPFAR, and the low prices from Indian Generic
Manufacturers. More recently, an Indian Generic Pharmaceutical Firm installed a new
plant only minutes away from SMM, also training Mozambican staff in India, and is
already selling some of its production to the Mozambican Ministry of Health. It was
found, however,  that this firm did not promote local  acquisition of managerial  and
more complex technical skills for their Mozambican staff,  limiting the possibility of
autonomy should the foreign staff leave. In a context where the State is responsible for
the majority of  medicines procurement,  the Ministry of  Health and the Ministry of
Industry and Commerce have yet  to formulate a  policy for the two pharmaceutical
plants installed in the country or to include them in their strategic plans.
4 The case of the EMOFAR factory in the 1980s and the more recent SMM project and
Indian private subsidiary show that Mozambique’s political willingness to foster local
production of medicines is highly dependent on capital, technological and managerial
transfers  and  circulation  from  foreign  actors.  Although  the  Mozambican  health
authorities did sometimes adapt the knowledge and objectives of these enterprises into
their priorities, so far, they have failed to support the plants in the long term with
specific health, fiscal or industrial policies. This situation thus questions whether the
status of medicines in Mozambique, which were regarded as strategic public goods that
required  local  production  for  economic,  political  and  access  to  health  reasons,  is
changing.
5 This article draws on work for a PhD thesis that describes the dynamics of knowledge
and  skills  transfer  in  industrial  pharmacy  between Mozambican  and  international
professionals,  focusing  especially  on  the  SMM  project.  The  methodology  included
interviews,  on  site  observations  at  the  SMM  plant  and  the  gathering  of  official
documents and archives on past local production experiences in Mozambique.
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Image: Mozambique’s SMM employees packing medicines in 2018. Photo by the Brazilian
Cooperation Agency (ABC).
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